Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000335 · ClinicalTrials.gov registry record · Phase 2
Activity Monitoring Assessment of Opiate Withdrawal - 4
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000335: Completed Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00000335 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000335, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.
Interventions
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1995-09-30 |
| Est. Completion | 1996-05-20 |
| Phase | Phase 2 |
What the finished NCT00000335 record still lists
NCT00000335 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Morphine is the first listed.
NCT00000335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000335 about?
NCT00000335 is a clinical study titled "Activity Monitoring Assessment of Opiate Withdrawal - 4". The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdraw...
What is the current status of trial NCT00000335?
This trial is currently completed. It is a Phase 2 study. The study started on 1995-09-30. Estimated completion is 1996-05-20.
What interventions are being tested in trial NCT00000335?
The interventions under investigation include: Morphine (DRUG).
Who is sponsoring clinical trial NCT00000335?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI